Aurora Cannabis Inc Total Liabilities

Latest as of June 2026: $93.79 Million USD

Aurora Cannabis Inc total liabilities. Based on the latest financial reports, Aurora Cannabis Inc (ACB) has total liabilities worth $93.79 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ACB asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Aurora Cannabis Inc (2007–2026)

Total liabilities of Aurora Cannabis Inc from 2007 to 2026. This chart illustrates how Aurora Cannabis Inc's total liabilities have evolved over time, based on quarterly financial data. Explore ACB long-term investment intensity to see how much of total assets are deployed in long-term investments.

Aurora Cannabis Inc Competitors by Total Liabilities

The table below lists competitors of Aurora Cannabis Inc ranked by their total liabilities.

Company Country Total Liabilities
Sichuan Langsha Holding Ltd
SHG:600137
China CN¥139.62 Million
Sam Yung Tradi
KO:002810
Korea ₩105.96 Billion
BenQ Materials Corp
TW:8215
Taiwan NT$15.72 Billion
Zhejiang Power New Energy Co. Ltd. A
SHG:688184
China CN¥399.58 Million
PharmaEngine
TWO:4162
Taiwan NT$112.86 Million
Quarterhill Inc
TO:QTRH
Canada CA$115.32 Million
Eurobio Scientific SA
PA:ALERS
France €78.26 Million
BRT Realty Trust
NYSE:BRT
USA $530.78 Million

Liability Composition Analysis (2007–2026)

This chart breaks down Aurora Cannabis Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Aurora Cannabis Inc asset portfolio.

Liquidity & Leverage Metrics

Aurora Cannabis Inc Total Liabilities Ratios Explained

Aurora Cannabis Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 5.36 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.18 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.15 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Aurora Cannabis Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Aurora Cannabis Inc (2007–2026)

The table below shows the annual total liabilities of Aurora Cannabis Inc from 2007 to 2026.

Year Total Liabilities Change
2026-03-31 $89.49 Million -63.12%
2025-03-31 $242.67 Million +2.30%
2024-03-31 $237.22 Million -41.38%
2023-03-31 $404.64 Million 0.00%
2022-03-31 $404.64 Million -41.01%
2021-03-31 $685.97 Million -14.53%
2020-03-31 $802.56 Million -34.95%
2019-03-31 $1.23 Billion +267.34%
2018-03-31 $335.87 Million +222.60%
2017-03-31 $104.11 Million +727.59%
2016-03-31 $12.58 Million +29.78%
2015-03-31 $9.69 Million +1707.93%
2014-03-31 $536.18K +1865.56%
2013-03-31 $27.28K -64.94%
2012-03-31 $77.81K +403.31%
2011-03-31 $15.46K +1.05%
2010-03-31 $15.30K +84.01%
2009-03-31 $8.31K +26.64%
2008-03-31 $6.57K 0.00%
2007-03-31 $6.57K --

About Aurora Cannabis Inc

NASDAQ:ACB USA Drug Manufacturers - Specialty & Generic
Market Cap
$331.74 Million
Market Cap Rank
#15632 Global
#3723 in USA
Share Price
$5.24
Change (1 day)
+0.96%
52-Week Range
$2.58 - $5.57
All Time High
$1416.62
About

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis… Read more